Time to rethink immunosuppression by mTOR inhibitors?

Marcus D. Säemann, Giuseppe Remuzzi

Research output: Contribution to journalArticlepeer-review

Abstract

Several surprising findings indicate that pharmacological blocking of the multifunctional enzyme mTor fosters distinct differentiation programs in different immunocompetent cells. These data might lead to a striking change in our view of the role that mTor inhibition should have in immunosuppressive therapy for allogeneic transplant recipients.

Original languageEnglish
Pages (from-to)611-612
Number of pages2
JournalNature Reviews Nephrology
Volume5
Issue number11
DOIs
Publication statusPublished - Nov 2009

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Time to rethink immunosuppression by mTOR inhibitors?'. Together they form a unique fingerprint.

Cite this